CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.3998
+0.0737 (22.60%)
May 9, 2025, 4:00 PM EDT

CytoDyn Cash Flow Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '24 May '23 May '22 May '21 May '20 2015 - 2019
Net Income
-49.84-79.82-210.82-176.47-139.94
Upgrade
Depreciation & Amortization
0.030.180.781.82.03
Upgrade
Other Amortization
1.652.23.053.662.05
Upgrade
Asset Writedown & Restructuring Costs
---10.05-
Upgrade
Stock-Based Compensation
2.424.286.2410.436.55
Upgrade
Other Operating Activities
23.1149.26127.8158.0862.09
Upgrade
Change in Accounts Receivable
----0.09
Upgrade
Change in Inventory
--2.06-79.36-19.15
Upgrade
Change in Accounts Payable
10.77-3.1-2.7153.0119.04
Upgrade
Change in Other Net Operating Assets
0.891.9-4.131.23-1.58
Upgrade
Operating Cash Flow
-10.98-25.11-77.72-117.57-68.8
Upgrade
Capital Expenditures
----0.12-0.04
Upgrade
Investing Cash Flow
----0.12-0.04
Upgrade
Long-Term Debt Issued
2.310.9-10015
Upgrade
Total Debt Issued
2.310.9-10015
Upgrade
Long-Term Debt Repaid
----0.95-2.19
Upgrade
Total Debt Repaid
----0.95-2.19
Upgrade
Net Debt Issued (Repaid)
2.310.9-99.0512.82
Upgrade
Issuance of Common Stock
9.4426.2342.6222.2756.69
Upgrade
Repurchase of Common Stock
----0.78-0.09
Upgrade
Preferred Dividends Paid
----0.24-
Upgrade
Dividends Paid
----0.24-
Upgrade
Other Financing Activities
-2.815.3917.05-3.16
Upgrade
Financing Cash Flow
11.7529.9348.01137.3579.67
Upgrade
Net Cash Flow
0.774.82-29.7119.6510.83
Upgrade
Free Cash Flow
-10.98-25.11-77.72-117.7-68.85
Upgrade
Free Cash Flow Margin
---29219.17%--
Upgrade
Free Cash Flow Per Share
-0.01-0.03-0.12-0.20-0.16
Upgrade
Cash Interest Paid
0.050.020.060.15-
Upgrade
Levered Free Cash Flow
-43.05-31.93-102.8715.22-58.13
Upgrade
Unlevered Free Cash Flow
-39.28-24.44-90.825.38-39.4
Upgrade
Change in Net Working Capital
30.433.536.96-72.371.29
Upgrade
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.